An 88-year-old woman with a CFS of 5 is reviewed in primary care. She has osteoporosis (T-score -2.8 at femoral neck) and has been on Alendronic acid ...

Question

An 88-year-old woman with a CFS of 5 is reviewed in primary care. She has osteoporosis (T-score -2.8 at femoral neck) and has been on Alendronic acid for 6 years. She has had no fractures during treatment. She asks if she should continue. What is the MOST appropriate advice?

Accepted Answer

Arrange a DXA scan and consider a drug holiday if T-score is above -2.5 at the femoral neck

Answer

Continue Alendronic acid indefinitely as she remains at risk

Answer

Stop Alendronic acid immediately with no further assessment

Answer

Switch to Denosumab as it is more effective long-term

Answer

Switch to Raloxifene for the next 5 years

uk-dgm MCQ (SBA): Bisphosphonate Drug Holiday Assessment

An 88-year-old woman with a CFS of 5 is reviewed in primary care. She has osteoporosis (T-score -2.8 at femoral neck) and has been on Alendronic acid for 6 years. She has had no fractures during treatment. She asks if she should continue. What is the MOST appropriate advice?